April 2018 Vol XLII Issue 4
DISPATCHES FROM THE GUILD CONFERENCE, SERIES #11How to Grade IBD Disease Activity in Your Daily Practice
A clear understanding of disease activity can facilitate better care for IBD patients by addressing the impact of disease as well as risk of progression. The aim of this review is to discuss accessible measures of disease activity in IBD that can be used regularly in the office with the goal of facilitating consistent clinic care, use of a shared vocabulary for IBD activity and to provide an objective basis for treatment and assessment of treatment response.
FRONTIERS IN ENDOSCOPY, SERIES #42Endoscopic Ultrasound-Guided Gallbladder Drainage
Here we discuss EUS-GBD, an evolving technique that can be an alternative to PTGBD when treating acute or chronic cholecystitis in high-risk surgical patients, and also has promising results when used for long-term or definitive treatment.
NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #174Nutritional Care of the Patient with Eosinophilic Esophagitis
Dietary elimination is an effective treatment for initial and long-term management of EoE. However, with the elimination of food groups, concerns arise for nutritional risk and quality of life. In this article we discuss the importance of providing patients with resources and education to teach food avoidance techniques on the prescribed elimination diet, as well as strategies to implement a diet that is allergen free, nutritionally dense, and diverse enough to maintain adherence, nutrition status and QoL. Successful EoE treatment with dietary modification requires a multidisciplinary approach, with gastroenterologists, allergists and dietitians.
THE MICROBIOME AND DISEASE, SERIES #4The Microbiome and the Heart
In this article, we discuss further understanding the gut microbiome along with its effect on metabolites and cardiovascular health. This understanding will give us opportunities to develop new test and therapeutic approaches to arteriosclerosis. In the future, stool transplantation with lean or low risk for cardiovascular disease microflora may be a way of treating patients who are susceptible to arteriosclerosis.
GASTROINTESTINAL MOTILITY AND FUNCTIONAL BOWEL DISORDERS, SERIES #24Upgrade Your Dysphagia Expertise - How to Diagnose Oculopharyngeal Muscular Dystrophy
Oculopharyngeal muscular dystrophy (OPMD) is rare, adult-onset, familial muscular dystrophy, which has been mainly characterized clinically by progressive dysphagia and ptosis. In this article, we present our experience with three patients with OPMD and the challenges in the diagnosis and treatment.
A SPECIAL ARTICLEHepatitis C Screening Among Baby Boomers at Risk for Hepatitis B
The Centers for Disease Control (CDC) recommends that baby boomers (adults born between 1945-1965) be screened for hepatitis C (HCV). Patients with HCV are at increased risk of co-infection with hepatitis B (HBV). In this article, we investigate HCV screening rates in a baby boomer cohort with chronic HBV or at high-risk for HBV infection from a large healthcare system.
A CASE REPORTNecrotizing Rash Associated with Autoimmune Hepatitis
Living with HHT: Understanding and Managing Your Hereditary Hemorrhagic Telangiectasia
It was a big task when author Sara Palmer PhD set out to write a book entitled Living with HHT. Hereditary Hemorrhagic Telangiectasia (HHT) is a complex, multisystem disorder that presents in many disparate ways that are not intuitive or easily understood by many physicians.
Utility of Magnetic Resonance Enterography in Pediatric Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is increasing in incidence in the pediatric population, and magnetic resonance imaging (MRI) has become increasingly utilized in both adult and pediatric patients with IBD to assess extent of disease and to categorize severity. In pediatrics, MR enterography (MRE) has the advantage of allowing soft tissue visualization with no associated radiation.
Astrovirus Infections in Children:An International Perspective
Astrovirus is an RNA virus associated with typically acute and self-limiting diarrhea; however, the epidemiology of this infection in geographic areas with higher levels of pediatric undernutrition is poorly understood. In order to characterize this infection in this specific group, a consortium group called The Etiology, Risk Factors, and Interactions of Enteric Infection and Malnutrition and the Consequences for Child Health and Development (MAL-ED) Study evaluated children
ENTYVIO® (VEDOLIZUMAB) SHOWS HIGHER RATES OF MUCOSAL HEALING VERSUS TNFa-ANTAGONIST THERAPY IN ULCERATIVE COLITIS AND CROHN'S DISEASE PATIENTS IN COMPARATIVE EFFECTIVENESS REAL-WORLD DATA ANALYSIS
OSAKA, Japan - New clinical study also provides data for Entyvio® in inducing complete mucosal healing and endoscopic remission, particularly in bio-naive patients
BASF LAUNCHES HEPAXA AS FIRST DEDICATED PRODUCT IN THE U.S. TO HELP PATIENTS MANAGE NON-ALCOHOLIC FATTY LIVER DISEASE
FLORHAM PARK, NJ and ANN ARBOR, MI BASF Corporation is introducing HepaxaTM, a product that can help tens of millions of patients manage Non-Alcoholic Fatty Liver Disease (NAFLD), one of the most common forms of chronic liver disease.
CRH MEDICAL CONFIRMS THAT ANCILLARY OPPORTUNITIES ARE IMPERATIVE TO WITHSTANDING GI REIMBURSEMENT PRESSURES
Join CRH Medical Corporation to learn more about the ancillary opportunities available to gastroenterologists at Digestive Disease Week on Monday, June 4th at 1:15 pm in the DDW Product Theater. Speakers Jay Kreger, President of CRH Anesthesia, and Dr. Mitchel Guttenplan, Medical Director for CRH Medical Corporation, discuss. Lunch will be provided.